Discussing on thrombosis and hemorrhage in cancer

The aim of ICTHIC is to review the recent advances in the understanding of the pathogenesis, prevention and treatment of thrombotic and hemorrhagic complications in cancer patients, both from the basic and clinical research points of view.

The major topics of the conference are:

Anticoagulant Treatment (VTE, ATE)

Anticoagulant Primary Prophylaxis

Antithrombotic Drugs

Arterial Thrombosis

Bleeding Issues

Complement-driven Thrombotic Syndromes

Congenital and Acquired Risk Factors

Disseminated Intravascular Coagulation (DIC)

Drug-Drug Interactions

Epidemiology

Fibrinolysis

Gender- and Age-related Issues

Hemostasis in Cancer Biology

Heparin-induced thrombocytopenia (HIT)

Hypercoagulation and Biomarkers

Immunotherapy and Target Therapy related VTE

Inflammation

Laboratory Assays for Hypercoagulability

Mechanisms of Thrombosis and Bleeding in Cancer

Microangiopathies

Microparticles

Proteases

Role of Antithrombotics in Cancer Survival

Thrombocytopenias

Thrombotic complications post BMT

Thrombotic complications post CAR-T Therapy

Tumor Cell/Vascular Cell Interactions

Vascular Biology

VOD/SOS